MarkNtel Advisors, a leading market research and consulting firm, has announced the release of its latest study titled Connected Drug Delivery Devices Market Research Report Forecast (2025-2030). This report provides a detailed assessment of the Connected Drug Delivery Devices Market, covering its evolving dynamics, emerging trends, key growth drivers, major challenges, and competitive landscape.
Designed to guide investors, stakeholders, and business leaders, the research aims to deliver valuable insights for strategic planning, risk assessment, and investment decision-making in the years ahead.
Market Timeline Overview
- Historical Years: 2020-23
- Base Years: 2024
- Forecast year - 2025-2030
This helps businesses identify emerging opportunities, assess market risks, and develop data-driven strategies for long-term success.
In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Download a FREE PDF Sample of the Report and Discover the market potential, platform-specific insights, and key industry trends.
Connected Drug Delivery Devices Market Outlook
According to the report, The Global Connected Drug Delivery Devices Market size is valued at USD 4.2 Billion in 2024 and is projected to reach USD 11 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 17% during the forecast period, i.e., 2025-30. This growth in the market is due to an increasing number of chronic diseases or NCDs such as diabetes, asthma, cardiovascular, etc. in the world today. According to the WHO, approximately 41 million people are killed every year by chronic diseases that make up about 71% of the overall deaths occurring around the world. Chronic disease cases are on a rise despite the increase in life expectancy rate with proper public healthcare facilities developed worldwide. Intake of substances like alcohol and tobacco contributes to major health hazards. Moreover, having a sedentary lifestyle also contributes to such increasing cases of chronic diseases all over the world. As per the estimates of WHO, at the current trend, by 2050 about 86% of all deaths will be from chronic diseases.
The growth of the market is projected to be driven primarily by massive investments by the US government in expansions of industries like construction, transportation, corporate, & hospitality, among others. Consequently, the demand for facility management services is on an unprecedented rise to improve the overall operational efficiency & productivity of businesses with increased cost-effectiveness.
The report also examines consumer preferences, regulatory impacts, and investment trends that will shape the market’s trajectory over the next decade.
Connected Drug Delivery Devices Market Drivers:
Rising Cases of Cardiovascular Diseases (CVD) – Globally, most of the deaths happen due to Chronic diseases. CVD is the leading cause of them, as these account for more than 30% of all deaths worldwide. The deaths attributed to CVD have moved up from approximately 12.1 million in 1990 to around 70% and have reached 20.5 million in 2021, reveals the World Heart Foundation. This growth is largely attributed to the increasing population all over the world. This is because globally, the death rate of CVD went down from 354.5 deaths per 100,000 people in 1990 to 239.9 deaths per 100,000 people in 2019. The decreasing birth rate globally which translates into a growing old-age population will raise the incidence of CVD further. The growing number of CVD cases will increase the demand for medication and rehabilitation associated with it. However, the optimum utilization of drugs for CVD is critically important for its effectiveness. Hence, the continuity and drug efficiency coupled with proper monitoring of daily dozes by the patient and the doctor will fuel the demand for connected drug delivery devices.
View Full Report (All Data, In One Place) and Explore in-depth analyses, technological trends, and investment patterns.
Connected Drug Delivery Devices Market Segmentation
The study categorizes the Connected Drug Delivery Devices Market into various segments and sub-segments, each analyzed for its size, growth potential, and contribution to the overall industry.
By Device Type
- Connected Sensors Devices
- Inhalers
- Injectors
- Auto-Injectors
- Pen-Injectors
- On-Body Connected Devices
- Implanted Connected Devices
By Connectivity
- Bluetooth Enabled Devices
- Near-Field Communication Enabled Devices
- Cellular Enabled Devices
- Wide Area Network Enabled Devices
By End User
- Hospitals
- Clinics
- Homecare
By Administration Route
- Parenteral
- Inhalational
- Homecare
By Application
- Chronic Diseases
- Asthma
- Cardiovascular Diseases
- Diabetes
- Others
- Personalized Medicines
- Remote Patient Monitoring
Geographical Analysis
The report presents detailed insights into the market’s geographical expansion, highlighting key trends and opportunities across the following geographies:
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Talk to Our Industry Analyst and Get personalized insights into company strategies and regional market dynamics.
Leading Companies in Connected Drug Delivery Devices Market Worldwide: Players, Analysis & Future Outlook
The top players in the Connected Drug Delivery Devices Market include Medtronic, Insulet, Tandem Diabetes Care, Bigfoot Biomedical (Abbott), Phillips–Medisize, West Pharmaceutical Services, Inc., Roche, Becton Dickinson and Company, Cohero Health Inc. (Aptar), Sagentia Innovation, CeQur, E3D Elcam Drug Delivery Devices, BIOCORP, Gerresheimer AG, Ypsomed AG, Nemera, and Others.
Key Highlights of the Report
- Comprehensive Market Overview: In-depth analysis of market size, share, and forecasts from 2025 to 2030.
- Growth Drivers & Challenges: Clear insights into factors feeling or restraining market expansion.
- Investment & Regulatory Insights: Evaluation of key policies, funding trends, and collaborations influencing industry performance.
- Competitive Landscape: Detailed profiles of leading companies, including product portfolios, business strategies, financials, and recent developments such as mergers & acquisitions.
Analytical Tools: Application of SWOT Analysis, PESTEL Analysis, and Porter’s Five Forces Model to assess competition and external influences
Browse through our flexible pricing plans and choose the package that best fits your business needs whether you require a single-user license, corporate access, or customized insights. Once you select the plan that suits your requirements, you can purchase and instantly access the full report online – https://www.marknteladvisors.com/pricing/connected-drug-delivery-devices-market.html
Frequently Asked Questions (FAQ)
1. What is the projected growth rate of the Connected Drug Delivery Devices Market?
2. What are the major factors driving this market’s growth?
3. Which regions are expected to lead the Connected Drug Delivery Devices Market?
4. Who are the prominent players in the Connected Drug Delivery Devices Market?
5. How is the competition structured in this market?
6. How can I access the full report?
Others Reports:
- https://johnryanwork0.wixsite.com/future-trends-market/post/gcc-sports-drinks-market-trends-opportunities-9-89-cagr-growth
- https://futuremarketanalysiss.blogspot.com/2025/12/gcc-warehouse-automation-market.html.html
- https://medium.com/@johnryanwork0/why-the-gcc-private-5g-network-market-is-a-strategic-priority-for-enterprises-977e23451e1e
- https://open.substack.com/pub/johnryanwork0/p/how-indias-sugarcane-market-is-powering?r=6zto2j&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true
About Us
MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.
Reach Us:
MarkNtel Advisors
Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 8719999009
Email: sales@marknteladvisors.com
Website: https://www.marknteladvisors.com
We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.